DipCatcherDipCatcher by KAWUMS
€FRA…
£LON…
$NYC…
₿BTC24/7
Next analysis …Last run 06:05 · 31 4–5 ★ · 177 3 ★
Market
3IN.L395.00 p+0.1%8TRA.DE€33.58-1.2%A$169.90-1.8%AAF.L273.20 p-4.2%AAL.L3,949.00 p-2.4%AAPL$342.94-0.2%AAVE$148.57-0.5%ABBV$282.68-1.0%ABDN.L232.40 p-2.6%ABF.L1,933.50 p-0.5%ABNB$175.46+1.0%ABT$104.06-0.8%ACN$236.93+3.2%ADA$0.2161-0.9%ADBE$247.09+0.8%ADI$394.35-0.3%ADM.L3,724.00 p-1.6%ADP$287.03-0.6%ADS.DE€159.05+0.3%AEP$124.72-1.9%AFL$118.67-1.1%AFX.DE€32.46-0.9%AIR.DE€192.24-3.4%AIXA.DE€31.52-4.2%AJG$253.01-0.7%ALGO$0.1115+1.6%ALL$246.85-0.4%ALV.DE€426.60-1.7%AMAT$413.11+0.9%AMD$538.05+1.8%AME$247.22-0.4%AMGN$424.94-1.7%AMT$183.03-1.2%AMZN$262.45+5.0%ANET$182.95+3.4%ANTO.L3,310.00 p-2.6%AON$289.74-1.0%APD$298.65-0.3%APH$80.28+1.2%APO$110.95+0.2%APP$269.12+1.1%AT1.DE€1.36-4.1%ATOM$1.74-0.1%AUTO.L542.00 p-0.7%AV.L706.60 p-0.9%AVAX$9.47-1.4%AVGO$334.59+1.8%AXP$316.41+0.9%AZN.L12,438.00 p-0.1%AZO$3,097.88-0.7%BA$191.42+0.6%BA.L1,933.50 p-2.5%BAB.L941.20 p-2.1%BAC$50.39-1.6%BARC.L413.80 p-4.4%BAS.DE€52.47-1.4%BATS.L4,435.00 p-0.5%BAYN.DE€43.38-2.4%BBY.L827.00 p-1.5%BC8.DE€34.58-0.7%BCH$274.69-2.0%BDX$190.74-0.5%BE$226.22+2.2%BEI.DE€82.22+0.5%BFSA.DE€33.30-2.1%BGEO.L12,210.00 p-2.9%BKG.L3,330.00 p-0.4%BKNG$162.60-0.5%BKR$55.81+0.2%BLK$1,124.60-0.9%BLND.L415.20 p-0.5%BME.L276.60 p-3.4%BMW.DE€57.02-0.1%BMY$58.83-1.5%BNB$727.72-0.4%BNR.DE€63.46-2.4%BNY$142.44-0.6%BNZL.L2,746.00 p-3.7%BOSS.DE€38.52+1.4%BP.L616.40 p+0.4%BPT.L398.50 p-1.4%BRBY.L1,112.00 p+0.9%BRK-B$532.23+0.0%BSX$45.05+1.5%BT-A.L208.30 p-0.7%BTC$81,468.05-0.5%BTRW.L310.30 p-0.5%BX$107.09+0.5%C$121.69-2.1%CAH$252.65-0.6%CARR$55.21+0.4%CAT$725.79-0.7%CB$356.27-1.0%CBK.DE€36.84-2.7%CCC.L4,918.00 p-3.6%CCEP.L8,435.00 p+0.4%CCH.L4,532.00 p+2.4%CDNS$325.86+2.0%CEG$263.19-3.0%CI$298.50-1.3%CIEN$344.20+3.4%CL$93.39-0.8%CMCSA$21.900.0%CME$293.53-0.1%CMI$522.13-1.7%CNA.L148.00 p-1.7%COF$199.83-0.9%COHR$232.02-0.4%COIN$168.45-2.7%CON.DE€68.58-2.0%COP$145.24-0.9%COR$340.00-0.3%COST$995.53+0.6%CPG.L$32.89+1.0%CRDA.L3,594.00 p-0.8%CRH$83.18-0.5%CRM$242.45+0.7%CRWD$228.10+0.3%CSCO$106.50-0.8%CSX$47.88-1.6%CTAS$212.30-0.7%CTEC.L236.80 p-0.5%CVS$92.68+0.3%CVX$224.37-0.3%CWK.L5,210.00 p0.0%D$62.21-2.1%DAL$74.63-1.0%DASH$193.53+2.3%DB1.DE€309.30-0.1%DBK.DE€28.12-4.1%DCC.L6,445.00 p+0.1%DDOG$260.36+5.4%DE$627.00-2.3%DELL$455.44+0.8%DGE.L1,769.00 p-1.2%DHER.DE€38.01-0.0%DHL.DE€57.22-1.7%DHR$224.43-2.0%DIS$109.59-0.9%DLR$173.00-1.7%DOGE$0.0791-0.7%DOT$1.13-2.0%DPLM.L7,560.00 p-4.2%DRX.L781.50 p-0.4%DTE.DE€25.77-0.5%DTG.DE€40.41-3.3%DUK$119.27-1.8%DVN$50.92+0.4%ECL$285.94-1.0%EDV.L4,121.00 p-1.8%ELV$430.23+0.5%EMG.L331.40 p-2.5%EMR$160.54-0.6%ENA$0.1868-1.2%ENR.DE€129.68-3.9%ENT.L440.26 p-0.8%EOAN.DE€17.57-1.6%EOG$157.65-0.2%EQIX$975.71-1.0%ETC$7.72-0.7%ETH$2,388.48-0.7%ETN$391.50+0.1%ETR$103.80-1.2%EVD.DE€62.05+0.5%EVK.DE€21.02-1.9%EVT.DE€2.66+3.5%EW$87.22+0.7%EXPN.L2,835.00 p-0.1%EZJ.L683.60 p+0.0%F$12.18-2.0%FANG$203.12-0.4%FAST$51.020.0%FCX$69.75+0.3%FDX$293.78+0.1%FIX$1,464.07+1.7%FME.DE€39.49-0.1%FNTN.DE€22.780.0%FPE3.DE€45.92+1.2%FRA.DE€61.40+1.8%FRAS.L873.43 p+0.6%FRE.DE€44.83-0.6%FRES.L2,663.00 p-2.1%FTNT$171.50+1.4%G1A.DE€68.30-1.3%G24.DE€80.25-0.1%GAW.L16,650.00 p-2.0%GBF.DE€55.00-2.1%GD$341.43-0.8%GE$311.28-0.8%GEV$908.44-1.4%GFT.DE€27.35+0.6%GILD$153.07-2.0%GLEN.L561.40 p-3.7%GLW$132.74+0.6%GM$82.75-1.4%GOOG$340.16+1.0%GOOGL$344.18+1.1%GRMN$286.16+0.5%GS$875.78-0.6%GSK.L1,868.50 p+0.3%GWW$1,318.06-0.9%GXI.DE€32.02+5.2%HAG.DE€86.42-1.6%HBAR$0.0832+0.3%HBR.L294.20 p+0.2%HCA$454.88-0.9%HD$309.88+0.1%HEI.DE€143.60-0.5%HEN3.DE€79.020.0%HFG.DE€3.03+0.3%HIK.L1,666.50 p+0.3%HILS.L2,955.00 p-2.6%HLE.DE€70.55-0.1%HLMA.L3,308.00 p-3.5%HLN.L379.40 p+1.1%HLT$346.04+0.3%HNR1.DE€274.400.0%HOC.L495.60 p-4.1%HON$209.98-0.7%HOOD$96.52-2.4%HOT.DE€363.20-2.5%HPE$55.87+1.3%HSBA.L1,382.80 p-3.2%HSX.L1,843.00 p-1.3%HUM$414.98+0.4%HWDN.L773.50 p-1.8%HWM$220.03-0.4%IAG.L407.80 p-1.7%IBM$236.39+1.8%ICE$158.40-2.0%ICG.L1,764.00 p-1.8%ICP$2.82-1.3%IFX.DE€50.93-2.8%IGG.L969.50 p-1.8%IHG.L$167.65-1.4%III.L2,400.00 p-2.8%IMB.L2,844.00 p-1.2%IMI.L2,888.00 p-3.1%INCH.L677.00 p-2.1%INF.L868.00 p-1.8%INPP.L135.80 p-1.3%INTC$92.03+2.4%INTU$325.62+0.1%INVP.L589.00 p-2.6%ISRG$433.18+1.5%ITH.L295.51 p-0.9%ITRK.L5,910.00 p-0.2%ITV.L65.40 p-1.4%ITW$270.17-0.8%JCI$148.22+1.9%JD.L92.44 p-1.4%JEN.DE€35.00-4.5%JMAT.L2,430.00 p-3.6%JNJ$253.79-0.7%JPM$333.53-1.8%JUN3.DE€21.84-1.0%KBX.DE€95.95-3.6%KEYS$335.86+1.4%KGF.L346.00 p-0.8%KGX.DE€33.48-1.8%KKR$87.00+0.9%KLAC$166.40+0.4%KMI$33.39-2.4%KO$93.42-0.5%KRN.DE€111.20-1.2%LAND.L653.00 p+0.4%LEG.DE€45.68-2.3%LGEN.L296.43 p-0.8%LHA.DE€7.08-1.4%LIN$503.44+1.0%LINK$11.96-0.7%LITE$834.51+1.3%LLOY.L101.50 p-3.2%LLY$1,240.34-1.3%LMP.L178.89 p-0.3%LMT$548.23-0.7%LOW$195.92-0.7%LRCX$272.20+3.1%LSEG.L8,726.00 p-0.5%LTC$59.29-0.6%LXS.DE€12.55-6.0%MA$616.40-0.2%MAR$390.70+0.7%MBG.DE€40.76-0.8%MCD$242.67-0.1%MCK$1,010.43+0.6%MCO$481.26-0.8%MDLZ$63.34-0.9%MDT$92.77-2.1%MET$99.58-1.2%META$705.44-0.5%MKS.L422.10 p+2.8%MMM$162.01-1.7%MNDI.L748.40 p-1.1%MNG.L310.10 p-1.3%MNST$46.80+2.3%MO$74.09-1.4%MPC$473.69-0.9%MPWR$1,253.66+3.5%MRK$143.63-1.6%MRK.DE€143.90-0.3%MRNA$226.89+4.1%MRO.L490.90 p+1.2%MRSH$188.50+0.1%MRVL$237.09+4.1%MS$178.47-1.2%MSFT$533.52+0.8%MSI$458.90-0.9%MTLN.L€48.20-2.2%MTO.L210.60 p+0.1%MTX.DE€342.50-2.9%MU$904.90+3.0%MUV2.DE€544.00-0.6%NDA.DE€144.30-6.2%NDAQ$93.20-0.8%NDX1.DE€37.32-4.7%NEAR$4.78-2.5%NEE$78.17-2.0%NEM$118.01-0.5%NEM.DE€76.05+3.4%NFLX$69.85-1.0%NG.L1,195.50 p-1.8%NKE$37.21+0.2%NOC$510.65-1.8%NOW$145.36+2.4%NSC$323.48-1.1%NUE$260.73+1.7%NVDA$217.09+1.4%NWG.L642.40 p-3.5%NXPI$230.19+0.4%NXT.L15,285.00 p-0.6%O$55.51-1.0%OCDO.L332.89 p+14.3%OKE$92.42-1.0%ONDO$0.4347-0.1%ONT.L206.40 p+3.2%ORCL$129.59+1.1%ORLY$89.07-0.2%OXY$62.72+0.5%P$127.09+2.5%PAF.L116.10 p-2.4%PAH3.DE€25.06+0.2%PANW$346.95+1.4%PCAR$108.42-2.2%PEP$133.57+1.6%PFE$29.44-0.5%PG$157.69-1.0%PGR$219.11+0.3%PH$966.26+0.3%PHP.L90.30 p-0.8%PLD$124.09-1.3%PLTR$194.15+4.4%PM$201.05-2.0%PNC$216.21-0.5%PRU.L890.20 p-1.8%PSA$295.69-0.9%PSH.L3,784.00 p-0.5%PSN.L1,232.00 p-2.3%PSON.L1,372.00 p-0.2%PSX$290.55-0.9%PUM.DE€24.59+1.4%PWR$618.41-2.1%QCOM$173.53+0.8%QIA.DE€41.58+1.4%QLT.L178.50 p-2.0%QNT$191.86-1.3%RAA.DE€613.00-0.5%RCL$281.97+1.5%RDC.DE€77.45+3.5%REGN$782.04-1.1%REL.L2,926.00 p+0.4%RHM.DE€1,039.60-4.6%RIO.L6,625.00 p-2.8%RKT.L5,522.00 p-1.1%RMV.L533.20 p-1.5%ROK$424.47-0.4%ROR.L492.80 p-0.0%ROSE.L302.00 p-2.9%ROST$238.66+0.7%RR.L1,304.40 p-3.4%RRTL.DE€30.95+0.8%RS1.L757.00 p-3.8%RSG$229.03-1.1%RSW.L5,250.20 p-4.5%RTO.L317.90 p+0.6%RTX$192.11-0.9%RWE.DE€56.76-3.9%SAP.DE€201.90+1.3%SAX.DE€37.54-1.2%SBRY.L361.90 p+2.7%SBUX$97.87+0.4%SCHW$89.58-2.6%SCT.L1,698.00 p-0.1%SDF.DE€13.26-5.7%SDLF.L905.50 p-0.6%SGE.L1,151.00 p+2.6%SGRO.L894.00 p-2.1%SHC.L140.00 p-0.8%SHEL.L3,930.50 p-0.2%SHIB$0.0000-0.4%SHL.DE€41.15-0.7%SHW$331.61-1.1%SIE.DE€255.95-5.4%SLB$49.09-0.8%SMIN.L2,616.00 p-2.6%SMT.L1,540.50 p-0.3%SN.L1,087.00 p+0.2%SNDK$1,371.12+5.5%SNPS$454.58-0.0%SO$89.27-2.1%SOL$104.29-0.6%SPG$202.49-1.4%SPGI$427.83-0.4%SPX.L7,260.00 p-1.5%SRE$81.74-2.0%SRP.L276.40 p+1.1%SSE.L2,497.00 p-3.0%STAN.L2,045.00 p-3.9%STJ.L1,057.00 p-1.0%STM.DE€15.60-3.3%STT$165.43-0.2%STX$660.81+3.4%SVT.L3,154.00 p-2.0%SY1.DE€100.65+1.2%SYK$297.94+1.1%T$23.20-1.0%TATE.L563.00 p-0.2%TBCG.L4,870.00 p-4.1%TDG$1,142.45+0.3%TEG.DE€10.53+0.3%TEL$212.33-0.1%TER$335.53+3.2%TFC$46.32-1.6%TGT$153.29-0.6%TJX$147.36+0.0%TKA.DE€13.81-3.8%TLX.DE€124.50-0.3%TMO$679.38-1.5%TMUS$156.09-1.9%TMV.DE€7.03+0.6%TRGP$292.80-0.7%TRV$385.45-1.1%TRX$0.3316-0.0%TSCO.L546.40 p+2.1%TSLA$368.06+3.8%TT$465.04+1.3%TUI1.DE€6.76+0.1%TW.L77.14 p-0.6%TXN$276.15-0.1%UBER$69.96-0.6%ULVR.L4,931.00 p-0.7%UNH$406.88+1.4%UNP$287.01-0.7%UPS$97.46-0.0%URI$1,025.00-0.5%USB$57.85-1.5%UTDI.DE€24.18+0.8%UTG.L449.20 p+0.6%UU.L1,467.00 p-1.9%V$402.92+0.1%VLO$433.31-2.6%VNA.DE€16.33-2.9%VOD.L119.43 p-2.1%VOW3.DE€69.36+1.0%VRT$206.08-0.2%VRTX$501.95+0.4%VST$149.70-1.5%VZ$44.15-1.4%WAB$286.74-0.0%WAF.DE€63.05-4.3%WCH.DE€86.30-2.5%WDC$352.21+6.1%WEIR.L2,562.00 p-4.5%WELL$233.51-0.6%WFC$81.80-2.5%WLD$0.5417+1.6%WM$226.41-0.2%WMB$70.38-1.3%WMT$118.70-0.1%WPP.L404.21 p-2.1%WTB.L2,603.00 p-0.3%XLM$0.1771-0.3%XMR$611.50+1.0%XOM$178.28-0.4%XRP$1.30-0.6%ZAL.DE€25.75+2.0%ZEC$1,130.35-1.8%
Dips
Consumer Cyclical-22.1%🔒Communication Services-14.7%🔒Financial Services-30.5%🔒Industrials-20.3%🔒Industrials-13.5%🔒Real Estate-28.7%🔒Financial Services-19.6%🔒Consumer Cyclical-16.2%🔒Industrials-31.6%🔒Financial Services-21.9%🔒Financial Services-13.8%🔒Financial Services-13.6%🔒Financial Services-21.1%🔒Basic Materials-24.3%🔒Energy-17.1%🔒Consumer Cyclical-16.7%🔒Communication Services-15.8%🔒Financial Services-16.1%🔒Consumer Cyclical-16.3%🔒Basic Materials-20.4%🔒Industrials-8.9%🔒Industrials-33.5%🔒Consumer Cyclical-16.6%🔒Basic Materials-11.0%🔒Consumer Cyclical-17.1%🔒Consumer Cyclical-15.1%🔒Financial Services-9.9%🔒Communication Services-13.8%🔒Industrials-8.2%🔒Consumer Cyclical-6.1%🔒Technology-7.5%🔒
As of 01:45

Regeneron Pharmaceuticals

REGN · NASDAQ · USD · Healthcare

$782.04
-1.1% today

Price

+16.5% since 20/07/2026
1m3m6m
6-week high$821.1720/07/202602/09/202619/10/2026

3 months · High $859.34 (-9.0%) · Low $637.06

What is happening

Regeneron Pharmaceuticals has fallen 5% since its 6-week high on 08/09/2026. How it continues – phase and signs – you see with a free account.

Free account · 3 stocks and coins a day

How deep is the dip?

  • from the 6-week high-4.8%

    Highest daily price: $821.17 on 08/09/2026 · reference of the assessment

  • from the 3-month high-9.0%

    Highest daily price in 3 months: $859.34 on 03/09/2026

  • from the 52-week high-9.0%

    Highest price in 52 weeks: $859.34 (Yahoo)

WatchMark as bought

Marking places no order – it only helps you keep track.

Your move on this one?Sign in to record it
Your take on this verdict?Sign in to react

Catalysts

18 min ago
News, last 10 days
no recent news
Next earnings
30/10/2026 · in 10 days
Last report
30/07/2026 +40.0% vs estimate

Trade levels

Free account · 3 stocks and coins a day

Why the engine says so

Free account · 3 stocks and coins a day

History for this stock or coin

Free account · 3 stocks and coins a day

Watch and alert

Free account · 3 stocks and coins a day

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma; Libtayo injection for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection to treat heterozygous familial hypercholesterolemia (HoFH); and Kevzara solution for rheumatoid arthritis. It has license and collaboration agreement with Bayer for the development and commercialization of EYLEA 8 mg and EYLEA; Alnylam Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for diseases by addressing therapeutic disease targets expressed in the eye and central nervous system; Intellia Therapeutics, Inc. to advance CRISPR/Cas9 gene-editing technology for in vivo therapeutic development for therapies focused on neurological and muscular diseases; Hansoh Pharmaceuticals Group Company Limited to acquire development and commercial rights for HS-20094, a dual GLP-1/GIP receptor; and Tessera Therapeutics, Inc. develops and commercializes TSRA-196, an investigational gene editing therapy for Alpha-1 antitrypsin deficiency. Additionally, the company has a strategic collaboration with Telix Pharmaceuticals Limited to develop and commercialize radiopharmaceutical therapies. It also has a strategic collaboration with CytomX Therapeutics, Inc. to create conditionally-activated bispecific cancer therapies. The company was incorporated in 1988 and is based in Tarrytown, New York.

Headquarters:
Tarrytown, United States
52-week range:
$572.75 – $859.34
Website:
regeneron.com

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search